NAZEM FARZAD
SEC insider (Form 3/4/5 filer). CIK 0001234663. Director at Nautilus Biotechnology, Inc. (NAUT). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in SEATTLE, WA.
Companies NAZEM FARZAD has filed insider reports for
- Nautilus Biotechnology, Inc. (NAUT): Director
NAZEM FARZAD
CIK: 0001234663
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NAUT
Nautilus Biotechnology, Inc.
Director